As of 2024-12-06, the Intrinsic Value of Resmed Inc (RMD) is
230.07 USD. This Resmed valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 249.02 USD, the upside of Resmed Inc is
-7.60%.
The range of the Intrinsic Value is 153.73 - 478.77 USD
230.07 USD
Intrinsic Value
Resmed Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
153.73 - 478.77 |
230.07 |
-7.6% |
| DCF (Growth 10y) |
191.11 - 567.89 |
280.38 |
12.6% |
| DCF (EBITDA 5y) |
194.42 - 369.32 |
265.86 |
6.8% |
| DCF (EBITDA 10y) |
228.42 - 448.55 |
315.25 |
26.6% |
| Fair Value |
186.71 - 186.71 |
186.71 |
-25.02% |
| P/E |
257.74 - 337.96 |
297.88 |
19.6% |
| EV/EBITDA |
147.15 - 288.76 |
221.59 |
-11.0% |
| EPV |
68.94 - 101.62 |
85.28 |
-65.8% |
| DDM - Stable |
70.62 - 292.54 |
181.58 |
-27.1% |
| DDM - Multi |
125.72 - 403.07 |
191.45 |
-23.1% |
Resmed Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
36,556.14 |
| Beta |
0.92 |
| Outstanding shares (mil) |
146.80 |
| Enterprise Value (mil) |
36,807.25 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.42% |
| Cost of Debt |
4.25% |
| WACC |
8.33% |